SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹525 Cr | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹525 Cr |
| Mar2025 | ₹474 Cr |
| Mar2024 | ₹414 Cr |
| Mar2023 | ₹343 Cr |
| Mar2022 | ₹369 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹525 Cr | 10.82 | |
| Mar2025 | ₹474 Cr | 14.47 | |
| Mar2024 | ₹414 Cr | 20.70 | |
| Mar2023 | ₹343 Cr | -7.09 | |
| Mar2022 | ₹369 Cr | - | |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,276.8 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
| MANKIND PHARMA | ₹93,967.8 Cr | -0.6% | 2.9% | -6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% |
-4.1% |
5.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses